Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Klinefelter syndrome in a Holstein-Friesian bull: a case report.

Irish veterinary journal·2026
Same author

Spatially-resolved optical monitoring of bioreactor cell growth.

Biomedical optics express·2026
Same author

Metagenomic assembled plasmids of the human microbiome vary across disease cohorts.

Scientific reports·2022
Same author

A bundle of infection control measures reduces postoperative sternal wound infection due to Staphylococcus aureus but not Gram-negative bacteria: a retrospective analysis of 6903 patient episodes.

The Journal of hospital infection·2022
Same author

The laparoscopy in emergency general surgery (LEGS) study: a questionnaire survey of UK practice.

Annals of the Royal College of Surgeons of England·2021
Same author

Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease.

Nature communications·2020

Related Experiment Video

Updated: Jul 6, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Brachytherapy for advanced prostate cancer bleeding.

R Thurairaja1, R Pocock, M Crundwell

  • 1Department of Urology, Royal Devon and Exeter Hospital, Exeter, UK. rthurairaja@doctors.org.uk

Prostate Cancer and Prostatic Diseases
|April 9, 2008
PubMed
Summary
This summary is machine-generated.

High-dose rate brachytherapy effectively treated intractable bleeding in advanced prostate cancer patients. This treatment resolved hematuria in most patients, offering a promising solution for managing this challenging symptom.

More Related Videos

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
07:17

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser

Published on: May 9, 2018

Related Experiment Videos

Last Updated: Jul 6, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
07:17

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser

Published on: May 9, 2018

Area of Science:

  • Oncology
  • Radiation Oncology
  • Urology

Background:

  • Advanced prostate cancer often presents with intractable prostatic bleeding, a difficult clinical challenge.
  • Current management options for severe hematuria in this patient group can be limited.

Purpose of the Study:

  • To evaluate the efficacy of intraurethral high-dose rate (HDR) brachytherapy for managing intractable prostatic bleeding in advanced prostate cancer.
  • To assess the resolution rate and recurrence of hematuria following HDR brachytherapy.

Main Methods:

  • A retrospective analysis of 23 advanced prostate cancer patients with intractable prostatic bleeding was conducted.
  • Patients received intraurethral HDR brachytherapy using Iridium-192 with a Micro-selectron HDR machine over a 5-year period.
  • Median patient age was 78 years, with a median Gleason score of 9.

Main Results:

  • Hematuria resolved in 19 out of 23 patients (82.6%) following intraureral HDR brachytherapy.
  • Of the patients who achieved resolution, 100% remained recurrence-free at the 6-month follow-up.
  • The treatment was generally well-tolerated, with no major complications reported in the abstract.

Conclusions:

  • Intraurethral high-dose rate brachytherapy is a potentially effective and palliative treatment modality for intractable hematuria in advanced prostate cancer.
  • This technique offers a viable option for symptom control in patients with limited treatment alternatives.